Windtree Therapeutics, Inc., a biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases. The company’s lead product candidate is ...
Hosted on MSN11mon
Windtree Therapeutics Announces Reverse Stock Split in Strategy to Boost Market ComplianceTrading on a split-adjusted basis will commence on April 22, 2024, under the same ticker symbol “WINT” but with a new CUSIP number, 97382D 501. The decision for the reverse stock split came ...
Starting February 21, 2025, the company’s common stock will trade on a split-adjusted basis on Nasdaq under the ticker symbol “WINT.” The reverse stock split will reduce the number of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback